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Available online 13 February 2014Abstract Bone marrow stromal cells (BMSCs) contain a subset of multipotent stem cells. Here, we demonstrate that
serotonin, a biogenic amine released by platelets and mast cells, can induce the smooth muscle differentiation of BMSCs.
Brown Norway rat BMSCs stimulated with serotonin had increased expression of the smooth muscle markers smooth muscle
myosin heavy chain (MHC) and α actin (α-SMA) by qPCR and Western blot, indicating smooth muscle differentiation. This was
accompanied by a concomitant down-regulation of the microRNA miR-25-5p, which was found to negatively regulate smooth
muscle differentiation. Serotonin upregulated serum response factor (SRF) and myocardin, transcription factors known to
induce contractile protein expression in smooth muscle cells, while it down-regulated Elk1 and Kruppel-like factor 4 (KLF4),
known to induce proliferation. Serotonin increased SRF binding to promoter regions of the MHC and α-SMA genes, assessed by
chromatin immunoprecipitation assay. Induction of smooth muscle differentiation by serotonin was blocked by the knock-down
of SRF and myocardin. Transforming growth factor (TGF)-β1 was constitutively expressed by BMSCs and serotonin triggered its
release. Inhibition of miR-25-5p augmented TGF-β1 expression, however the differentiation of BMSCs was not mediated by
TGF-β1. These findings demonstrate that serotonin promotes a smooth muscle-like phenotype in BMSCs by altering the balance
of SRF, myocardin, Elk1 and KLF4 and miR-25-5p is involved in modulating this balance. Therefore, serotonin potentially
contributes to the pathogenesis of diseases characterized by tissue remodeling with increased smooth muscle mass.© 2014 TheAuthors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.Introduction chondrocytes, adipocytes, fibroblasts, and smooth muscleBone marrow stromal cells (BMSCs, also frequently referred
to as bone marrow-derived mesenchymal stem cells) are
non-hematopoietic progenitor cells, containing a subset of
multipotent stem cells that can differentiate into osteocytes,Abbreviations: α-SMA, smoothmuscleα actin; BMSC, bonemarrow
stromal cell; KLF4, Kruppel-like factor 4; MHC, smooth muscle myosin
heavy chain; Myocd, myocardin; SRF, serum response factor; TGF-β,
transforming growth factor-β.
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1873-5061/© 2014 Published by Elsevier B.V. Open access under CC BY-NCcells given the appropriate milieu. Cells with a similar
phenotype to BMSCs can be found in various locations, but
their capacity for differentiation varies from one tissue to
another (Bianco et al., 2008). An increase in smooth muscle
mass is a key feature of diseases such as atherosclerosis and
bronchial asthma in which airway remodeling is associated
with expanded muscle mass. Local stem/progenitor stromal
cells can potentially contribute to the pathogenesis of these
diseases by differentiating into smoothmuscle cells. However,
the mechanisms underlying the differentiation of local stem/
progenitor stromal cells into smooth muscle cells have not
been elucidated.-ND license.
600 N. Hirota et al.Serotonin is a biogenic amine which is synthesized and
released by the enterochromaffin cells of the gut, neurons,
and mast cells. Serotonin is stored in platelets and released
when they are activated (Meuer et al., 1981). Serotonin
derived from pulmonary arterial endothelial cells has been
reported to induce a more smooth muscle-like phenotype of
pulmonary arterial smooth muscle cells in a co-culture system
(Gairhe et al., 2012). Moreover, the activation of platelets
has been reported in bronchial asthma and atherosclerosis,
providing a potential source for serotonin that might, in turn,
participate in the observed increase of smoothmuscle in these
pathologies (Borissoff et al., 2011; de Boer et al., 2012; Kowal
et al., 2006; Yamamoto et al., 1993).
In this study, we used BMSCs to model how local stem/
progenitor cells may contribute to disease pathogenesis by
examining the effects of serotonin on the differentiation of
BMSCs into smooth muscle-like cells. We explored the roles
of key transcription factors and microRNAs, which regulate
differentiation and proliferation of the cells by altering
expression of smooth muscle-related proteins. Additionally
we examined the potential role of TGF-β1 in the process.
Materials and methods
Cells
Rat BMSCs were isolated from femoral bones of 8 to
10 week-old male Brown Norway rats as previously described
(Karaoz et al., 2009). The ends of the femoral bone were cut
away and a 20-gauge needle was inserted into the shaft of the
bone. Bone marrow was extruded by flushing with culture
medium as described below. Marrow was dispersed by
pipetting, and filtered through a 70-μm mesh nylon filter (BD
Biosciences, Bedford, MA, USA). Filtered cells were subjected
to negative selection by CD45 using immunomagnetic cell
sorting (Miltenyi Biotec, Bergisch Gladbach, Germany). BMSCs
were characterized as CD29-positive, CD25-negative, CD90-
positive cells by flow cytometry. Cells were maintained in
DMEM with 10% FBS, 100 U/ml penicillin, and 100 μg/ml
streptomycin (Invitrogen, Carlsbad, CA, USA) at 37 °C under
5% CO2 and used for experiments between passages 1 and 9. All
animals were maintained in a conventional animal facility at
McGill University (Montreal, QC, Canada). Experimental
procedures were approved by the Animal Care Committee of
McGill University.
Serotonin stimulation
Prior to stimulation, cells were serum-starved with 0.1%
BSA-containing DMEM for 24 h. Cells were subsequently
stimulated with 10 μM serotonin for 24 h. Preliminary exper-
iments were performed using a range of concentrations of
serotonin from 0.01 to 100 μM.
Reverse transcription-quantitative PCR
RNAwas extracted using an RNeasymini-kit (Qiagen, Valencia,
CA, USA). Reverse transcription was performed using 500 ng of
RNA by an AffinityScript qPCR cDNA synthesis kit (Agilent
Technologies, Santa Clara, CA, USA). qPCR was performedwith iTaq SYBR green supermix with ROX (Hercules, CA, USA)
(see Table 1 for primer sequences). The cDNAwas amplified in
the StepOnePlus realtime PCR system (Applied Biosystems,
Foster City, CA, USA). Relative mRNA expression was cal-
culated using the “ΔΔCt” method. Individual data were
normalized against the housekeeping gene ribosomal S9.
Results were expressed as a fold change in expression over
the control.
Chromatin immunoprecipitation (ChIP) assay
ChIP assays were performed using an EZ-Magna ChIP A/G
chromatin immunoprecipitation kit (EMD Millipore, Billerica,
MA, USA), following the manufacturer's protocol. BMSCs were
plated at a density of 1 × 106 cells. Cells were starved for 24 h
prior to stimulation with 10 μM serotonin. Following a 24 h
serotonin stimulation, cells were fixed with 1% formaldehyde
and lysed with lysis buffer. Cell lysates were sonicated using a
Fisher Scientific Model 150T digital sonic dismembrator (Fisher
Scientific, Pittsburgh, PA, USA). Sonicated DNA/protein
complexes were subjected to immunoprecipitation with
either 5.0 μg of normal rabbit IgG as a control (Vector
Laboratories, Burlingame, CA, USA) or 5.0 μg of anti-serum
response factor (SRF) antibody (Santa Cruz, CA, USA) and 20 μl
of protein A/G magnetic bead slurry. Prior to immunoprecip-
itation 1% of each sheared DNA sample was reserved as the
input control. DNA was purified from immunoprecipitated
samples and subjected to quantitative PCR and conventional
PCR for myosin heavy chain (MHC, Myh11) and smooth muscle
α actin (α-SMA,Acta2) (see Table 1 for primer sequences). The
quantity of DNA was represented as a fold enrichment over
input control, normalized against immunoprecipitation with
the non-specific IgG control.
Knock-down of SRF and Myocd
siRNA against rat SRF and Myocd were purchased from
Dharmacon (SMARTpool, Thermo Fisher Scientific, Chicago,
IL, USA). BMSCs were transfected either with control siRNA
or siRNAs against SRF or Myocd at a 40 nM concentration
using a Lipofectamine 2000 transfection reagent (Invitrogen,
Carlsbad, CA, USA) following the manufacturer's protocol.
After 24 h, cells were subjected to serum-starvation
followed by serotonin stimulation.
Western blot
Serotonin-stimulated BMSCs were washed with ice cold
PBS and lysed in an ice cold extraction buffer (10 mM
Tris, 150 mM NaCl, 10 mM ethylenediaminetetraacetic acid
(EDTA), 1% NP-40, 1% deoxycholate, 0.05% sodium dodecyl
sulfate (SDS), 50 mM Sodium fluoride and 50 mM Sodium
pyrophosphate, supplemented by Complete protease inhib-
itor cocktail (Roche Applied Science, Penzberg, Germany)).
SDS PAGE was carried out using 8% polyacrylamide gels, and
proteins (20 μg/lane) were transferred to polyvinylidene
difluoride membranes. Membranes were blocked for 1 h at
room temperature with 5% skim milk in Tris–HCl buffer
containing Tween-20 (TBST). Membranes were then probed
with a series of antibodies: SRF (G-20, 1:200 dilution) and
Myocd (M-16, 1:200 dilution) (Santa Cruz, CA, USA), smooth
Table 1 Primer sequences.
Forward Reverse
Primers for quantitative PCR
S9 ATCCGCCAACGTCACATC CCGCCACCATAAGGAGAAC
SRF TTCAGACCTGCCTCAACTCG GGTTGGTGACTGTGAATGCTG
Myocardin CCGTGAAAGAGGCTATAAAAGG CTGTCATCTTCAAAGGCAAATG
Elk1 CACCAGTCCAAACCCCTTAG TCAACTCTTCAGATTTCTGGTTTG
KLF4 ACCAGATGCAGTCGCAAGTC ACAAGTGTGGGTGGCTGTTC
Myh11 CCAATCCTGGAGGCTTTCG CTCTCGTCCCTAGCCTGTC
ACTA2 TGCCATGTATGTGGCTATTCA ACCAGTTGTACGTCCAGAAGC
TGF-β1 CCTGGAAAGGGCTCAACAC CAGTTCTTCTCTGTGGAGCTGA
Primers for ChIP assays
Myh11 CTGCACGGGACCATATTTAGTCAGGGGGAG CTGGGCGGGAAACAACCCAAAAAGGCCAGG
ACTA2 AGCAGAGCAGAGGAATGCAGTGGAAGAGAC CCTCCCACTCGCTTCCCAAACAAGGAGC
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St. Stoughton, MA, USA), α-SMA (1:1000 dilution, Sigma-
Aldrich, St. Louis, MO, USA), GAPDH (6C5, 1:4000 dilution,
Millipore Corp., Billerica, MA, USA), Elk1 and KLF4 (1:1000
dilution, Cell Signaling Technology Inc., Danvers, MA, USA).
Proteins were visualized using secondary antibodies conjugated
to horseradish peroxidase (Amersham, Oakville, Ontario,
Canada) and enhanced chemiluminescence (ECL; Amersham)
on a FluorChem 8000 imaging system (Alpha Innotech, San
Leandro, CA, USA).
MicroRNA analysis
Total RNA was extracted using miRCURY RNA Isolation kit
(Exiqon, Woburn, MA, USA). Reverse transcription was per-
formed using 10 ng of total RNA by Universal cDNA Synthesis
Kit (Exiqon). qPCR was performed with primers and SYBR
green master mix (Exiqon). The cDNA was amplified in the
StepOnePlus realtime PCR system (Applied Biosystems, Foster
City, CA, USA). Relative mRNA expression was calculated using
the “ΔΔCt” method. Individual data were normalized against
the housekeeping gene U6. Results were expressed as a fold
change in expression over the control.
MicroRNA mimic and inhibitor
Chemically modified double-stranded RNAs designed to mimic
the endogenousmature ratmiR-25-5p, and chemicallymodified
single-stranded RNA designed to inhibit the endogenous mature
miR-25-5p and their negative control miRNAs were purchased
from Ambion (Austin, TX, USA). MicroRNA mimics and inhibitors
were transfected at a 40 nM concentration using a Lipofecta-
mine 2000 transfection reagent (Invitrogen) following the
manufacturer's protocol. After 24 h, cells were subjected to
serum-starvation followed by serotonin stimulation.
Measurement of cell proliferation
Cell proliferation was assessed using bromodeoxyuridine (BrdU)
uptake (FITC BrdU flow kit, BD Pharmingen, San Jose, CA, USA).
Cells were rendered quiescent by culturing for 24 h in themedium with 0.5% FBS. Medium was changed to 0.5% or 10%
FBS-containingmediumwith orwithout serotonin (10 μM). BrdU
was added 6 h later, and the cells were harvested after 18 h.
Cells were stained for BrdU and analyzed by flow cytometry as
recommended by the manufacturer.
TGF-β1 immunoassay
Total TGF-β1 release in BMSC culture supernatants was
measured using a Quantikine TGF-β1 sandwich enzyme
immunoassay (R&D Systems, Minneapolis, MN) according to
the manufacturer's protocol. Culture supernatants were
acidified prior to assay to activate latent TGF-β1 to its
immunoreactive form. The effects of TGF-β1 inhibition were
examined using SB431542 (1 μM, Sigma-Aldrich, Oakville,
ON, Canada), a specific kinase inhibitor.
Statistical analysis
Data were analyzed for statistical significance using
SigmaPlot 12 software (Systat Software Inc., San Jose, CA,
USA). All data are expressed as means + a standard deviation
(SD) with at least 3 independent observations per experi-
ment. Values of P ≤ 0.05 were considered to be significant.
Results
Serotonin induces smooth muscle differentiation
of BMSCs
To measure the effect of serotonin on the differentiation
of BMSCs, we stimulated BMSCs with increasing doses of
serotonin (0.01 μM–100 μM) for 24 h. At concentrations
above 0.01 μM, the mRNA expression levels of genes encoding
the smooth muscle specific proteins, myosin heavy chain (MHC,
Myh11) and smooth muscle α actin (α-SMA, Acta2), were
elevated as determined by reverse transcription quantitative
PCR (RT-qPCR, Fig. 1A). A supramaximal concentration of
10 μM was used for stimulation in subsequent experiments.
The increased expression of MHC and α-SMA was also
detected at the protein level by Western blot (Fig. 1B).
602 N. Hirota et al.However, serotonin stimulation had no effect on the
proliferation of BMSCs (Fig. 1C). These data indicate that
serotonin promotes a smooth muscle-like phenotype in
BMSCs.
Serotonin induces upregulation of SRF andmyocardin
and down-regulation of Elk1 and KLF4 in BMSCs
To investigate the mechanism of smooth muscle differentia-
tion of BMSCs, we measured the expression of putative
transcription factors. Serum response factor (SRF) and its
co-factor, myocardin (Myocd) have been reported to play
central roles in smooth muscle specific protein expression by
binding to a highly conserved element, the CArG (CC(A/T)6GG)
box in the non-coding region of their gene targets. Stimulation
of BMSCs with serotonin upregulated both SRF and Myocd as
assessed by RT-qPCR and Western blot. The expression of Elk1
and Kruppel-like factor 4 (KLF4), transcription factors report-
ed to promote proliferation of smooth muscle cells was
unchanged at the mRNA but decreased at the protein level
with serotonin stimulation (Figs. 2A and B).
SRF and Myocd induce smooth muscle differentiation
in serotonin-stimulated BMSCs
To confirm that serotonin induces the binding of SRF to the
promoters of smooth muscle specific protein genes, we
performed chromatin immunoprecipitation (ChIP) followed
by PCR analysis. Serotonin enhanced the binding of SRF to
Acta2 and Myh11 promoters (Figs. 3A and B), further
supporting the possibility that SRF drives smooth muscle
differentiation of BMSCs induced by serotonin.
To determine the requirement of SRF and Myocd in the
differentiation of BMSCs into smooth muscle cells, siRNA was
used to knock down both transcription factors and the
expression of SRF and Myocd, and MHC (Myh11) and α-SMA
(Acta2) was assessed by RT-qPCR with and without serotonin
stimulation. Serotonin-induced BMSC smooth muscle differen-
tiation was abolished by the knock-down of SRF (Fig. 3C). In
contrast, the knock-down of Myocd inhibited but did not
completely abolish the effect of serotonin on smooth muscle
differentiation despite a similar knockdown efficiency to that
of SRF (Fig. 3D). Importantly, knock-down of either SRF or
Myocd did not have any reciprocal effect on the expression of
the other (Figs. 3C and D).
miR-25-5p is down-regulated in serotonin-stimulated
BMSCs
MicroRNAs are small non-coding RNAs which have been
reported to regulate many cellular events, including differen-
tiation, by inhibiting translation and reducing the stability of
mRNAs. To determine whether microRNAs may be involved in
the differentiation of BMSCs into smooth muscle cells, we
screened BMSCs following serotonin stimulation for changes in
the expression of a series of microRNAs with known roles in
smooth muscle differentiation by RT-qPCR (Fig. 4A). Several
studies have demonstrated the roles of miR-143 and miR-145
in regulating the balance of proliferation and differentiation
in smooth muscle cells by targeting Elk1 and KLF4 whichpromote proliferation (Cordes et al., 2009). miR-26a has
been linked to the hypertrophy of smooth muscle cells
(Mohamed et al., 2010). miR-25-3p was also reported to
inhibit proliferation of smooth muscle cells by targeting
KLF4 (Kuhn et al., 2010). Despite the well documented roles
of mir-145, 143, 26a, and 25 in smooth muscle differenti-
ation, serotonin treatment had no effect on their expression
in BMSCs. However, serotonin down-regulated the expres-
sion of miR-25-5p. The role of miR-25-5p, synthesized from
the same pre-microRNA as miR-25-3p has not previously
been explored in the context of smooth muscle differenti-
ation. Prediction of the miR-25-5p binding site showed that
human miR-25-5p targets TGF-β1 and rat miR-25-5p targets
Smad2, which is in the downstream pathway of TGF-β1.
TGF-β1 has been reported to induce smooth muscle differen-
tiation of BMSCs (Fig. 6A) (Popova et al., 2010).miR-25-5p blocks smooth muscle differentiation
of BMSCs
We further pursued the effects of miR-25-5p on the
differentiation of BMSCs into smooth muscle-like cells by
both its over-expression and its inhibition. Forced expres-
sion of a miR-25-5p mimic inhibited the effect of serotonin
on Myocd expression and as a result, blocked the expression
of MHC (Myh11) and α-SMA (Acta2) as determined by
RT-qPCR (Fig. 5A). This effect was also confirmed by
Western blot (Fig. 5B). Moreover, inhibition of miR-25-5p
induced the expression of Myocd and smooth muscle specific
proteins (MHC and α-SMA, Fig. 5C). Of note, the expression
of SRF remained unaffected through both over-expression
and inhibition of miR-25-5p (Figs. 5A and C). These data
suggest that miR-25-5p inhibits smooth muscle differentia-
tion of BMSCs and that serotonin induces Myocd expression
by inhibiting the expression of miR-25-5p.TGF-β1 and miR-25-5p modulate serotonin-induced
smooth muscle differentiation of BMSCs
To investigate the mechanism by which serotonin induces the
upregulation of SRF and Myocd, we measured transforming
growth factor β (TGF-β)1, which is known to induce smooth
muscle differentiation of BMSCs (Popova et al., 2010). TGF-β1
induced the expression of Acta2 by qPCR (Fig. 6A). The
expression of TGF-β1 was upregulated in the presence of
anti-miR-25-5p (Fig. 6B), which was down-regulated with
serotonin stimulation (Fig. 4). Therefore, miR-25-5p targets
the TGF-β1 pathway. The expression of TGF-β1 mRNA was
upregulated with serotonin stimulation (Fig. 6C) and release
of TGF-β1 from BMSCs increased with serotonin stimulation
(Fig. 6D). However, a selective inhibitor of TGF-β1 receptor
kinases, SB431542 (1 μM) did not significantly affect the
smooth muscle differentiation and upregulation of SRF and
Myocd induced by serotonin (Fig. 6E). Therefore, TGF-β1 and
miR-25-5p, which targets the TGF-β1 pathway, modulate the
expression of SRF and myocardin. However, our results
demonstrate that the effects of miR-25-5p on serotonin-
induced smooth muscle differentiation of BMSCs are not
TGF-β1 dependent.
AB
C
Figure 1 Serotonin induces smooth muscle differentiation of BMSCs. A, BMSCs were stimulated with serotonin (0.01, 0.1, 1, 10,
100 μM) for 24 h following serum-starvation. mRNA of MHC (Myh11) was measured by quantitative PCR (right). Data are represented
as means + SD (n = 5) BMSCs were stimulated with 10 μM serotonin (5HT) for 24 h following serum-starvation. mRNA of MHC (Myh11)
and α-SMA (Acta2) were measured by quantitative PCR (middle and left). Data are represented as means + SD (n = 7). Statistical
significance was analyzed using unpaired t-test. B, Western blots were performed for myosin, α-SMA and GAPDH after a 24 h
stimulation with serotonin (left). The data are representative of 3 independent experiments with similar results. Densitometry was
performed for these 3 experiments (middle and right panels). C, Proliferation of BMSCs was measured by bromodeoxyuridine (BrdU)
incorporation after a 24 h stimulation with serotonin. Data are represented as means + SD (n = 4).
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The involvement of circulating progenitor cells in tissue
remodeling has been indicated in a number of diseases.
Smooth muscle progenitor cells have been shown to
contribute to atherosclerosis (Liu et al., 2004; Saiura et
al., 2001). Circulating fibrocytes are increased in asthma
patients with chronic airflow obstruction (Wang et al.,
2008). A relationship has also been reported between thecirculating fibrocytes and disease progression in idiopathic
pulmonary fibrosis (Bucala et al., 1994; Moeller et al., 2009).
The origins of these circulating progenitor cells are not
known, although some studies indicate that they might have
bone marrow origin (Ebihara et al., 2006; Sata, et al., 2002).
Our study was motivated by the possibility that cells
originating in the bone marrow may participate in distal
organ remodeling through their recruitment into the
circulation and their differentiation within the tissues.
604 N. Hirota et al.Additionally, local progenitor cells may likewise be influ-
enced to differentiate into smooth muscle. Bone marrow
stromal cells were studied to investigate whether serotonin
may promote the differentiation of progenitor cells into a
smooth muscle-like phenotype.
Serotonin was chosen for this study because of substantial
circumstantial evidence of its potential involvement in
tissue remodeling. Platelets and mast cells are potential
sources of circulating serotonin and a relationship between
asthma and platelets has been previously reported (Yamamoto
et al., 1993). More specifically platelets have been implicated
in the pathogenesis of airway remodeling using allergen-
driven models of asthma (Pitchford et al., 2008). Further-
more, serotonin is released from mast cells during theirctl 5HT
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were measured by quantitative PCR. Data are represented as means + SD (n = 6). Statistical significance was analyzed using unpaired
Student t-test.
606 N. Hirota et al.Recently, several studies have suggested that mesenchymal
progenitor cells may be involved in the pathogenesis of
asthma and atherosclerosis through their differentiation
and integration into remodeled tissues (Tang et al., 2012).
Human asthmatic patients demonstrate an accumulation of
myofibroblasts in the airway subepithelium with a phenotype
gradient from weakly to strongly positive smooth muscle-like
cells (Gizycki et al., 1997; Ramos-Barbon et al., 2010; Roche et
al., 1989) and cells possessing a BMSC phenotype increase in the
lungs in amousemodel of allergic asthma (Bentley et al., 2010).
These studies suggest that the recruitment of multipotent stem
cells and their differentiation in situ into smooth muscle might
contribute to the disease state.BMSCs have been also reported to have immunoregulatory
properties, influencing immune effector cell development,
maturation, and function as well as alloreactive T cell responses
(Jarvinen et al., 2008). In a mouse asthma model, administra-
tion of exogenous BMSC inhibited eosinophil infiltration and
decreased levels of T helper 2 cytokines (IL-4, IL-5 and IL-13) in
bronchial lavage (Nemeth et al., 2010). However, the effect of
BMSC administration on airway remodeling, especially the
increase of smoothmusclemass, has not yet been studied. The
present study emphasizes the necessity of a further investiga-
tion into the role of BMSCs in airway remodeling.
Here we have demonstrated that serotonin induces
smooth muscle differentiation of BMSCs by the synchronized
A B
C D
E
Figure 6 TGF-β1 and miR-25-5p modulate serotonin-induced smooth muscle differentiation of BMSCs. A, BMSCs were stimulated
with TGF-β1 (10 ng/ml) for 24 h following serum-starvation. mRNA of α-SMA (Acta2) was measured by quantitative PCR. Data are
represented as means + SD (n = 3). Statistical significance was analyzed using the unpaired t-test. B, BMSCs were transfected with
scrambled miRNA (miRNAscr) or an inhibitor of miR-25-5p (anti-miR-25-5p). mRNA of TGF-β1 was measured by quantitative PCR. Data
are represented as means + SD (n = 6). Statistical significance was analyzed using the Wilcoxon matched pair test. C, BMSCs were
stimulated with 10 μM serotonin (5HT) for 24 h following serum-starvation. mRNA of TGF-β1 was measured by quantitative PCR. Data
are represented as means + SD (n = 4). Statistical significance was analyzed using unpaired t-test. D, Concentration of TGF-β1 in the
culture medium was measured by ELISA. Data are represented as means + SD (n = 18). Statistical significance was analyzed using
unpaired t-test. E, BMSCs were stimulated with 10 μM serotonin (5HT) with and without 1 μM SB431542 for 24 h following
serum-starvation. mRNA of MHC (Myh11), α-SMA (Acta2), SRF, and Myocd were measured by quantitative PCR. Data are represented
as means + SD (n = 5).
607Serotonin augments smooth muscle differentiation of bone marrow stromal cellsupregulation of SRF and Myocd and down-regulation of Elk1
and KLF4. TGF-β1 and miR-25-5p modulate this balance.
Importantly, this study raises the possibility that serotonin
contributes to the pathogenesis of diseases such as airwayremodeling in asthma and atherosclerosis through the
augmentation of smooth muscle cells. Moreover, this is the
first report demonstrating the involvement of miR-25-5p in
the regulation of cellular events. Serotonin and TGF-β1 may
608 N. Hirota et al.play a role in the myofibroblastic, fibrotic, and smooth
muscle-like differentiation of progenitor cells and could be
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